FGF21 and obesity due to melanocortin 4 receptor deficiency: It has been demonstrated that FGF21 has a significant role in the progression of obesity.14 Indeed, obesity is characterized by resistance to FGF2115 and there is notable interest in the administration of FGF21 as a therapy for obesity.16 Recently, FGF 21 production was shown to be associated with BAT differentiation.